The sars-cov-2 ivermectin navarra-isglobal trial (saint) to evaluate the potential of ivermectin to reduce covid-19 transmission in low risk, non-severe covid-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial

  1. Chaccour, C.
  2. Ruiz-Castillo, P.
  3. Richardson, M.-A.
  4. Moncunill, G.
  5. Casellas, A.
  6. Carmona-Torre, F.
  7. Giráldez, M.
  8. Mota, J.S.
  9. Yuste, J.R.
  10. Azanza, J.R.
  11. Fernández, M.
  12. Reina, G.
  13. Dobaño, C.
  14. Brew, J.
  15. Sadaba, B.
  16. Hammann, F.
  17. Rabinovich, R.
Journal:
Trials

ISSN: 1745-6215

Year of publication: 2020

Volume: 21

Issue: 1

Type: Article

DOI: 10.1186/S13063-020-04421-Z GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus